Correlation Between Enorama Pharma and Xbrane Biopharma
Can any of the company-specific risk be diversified away by investing in both Enorama Pharma and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enorama Pharma and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enorama Pharma AB and Xbrane Biopharma AB, you can compare the effects of market volatilities on Enorama Pharma and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enorama Pharma with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enorama Pharma and Xbrane Biopharma.
Diversification Opportunities for Enorama Pharma and Xbrane Biopharma
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enorama and Xbrane is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Enorama Pharma AB and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and Enorama Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enorama Pharma AB are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of Enorama Pharma i.e., Enorama Pharma and Xbrane Biopharma go up and down completely randomly.
Pair Corralation between Enorama Pharma and Xbrane Biopharma
Assuming the 90 days trading horizon Enorama Pharma AB is expected to generate 0.55 times more return on investment than Xbrane Biopharma. However, Enorama Pharma AB is 1.82 times less risky than Xbrane Biopharma. It trades about 0.05 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about 0.01 per unit of risk. If you would invest 349.00 in Enorama Pharma AB on August 29, 2024 and sell it today you would earn a total of 27.00 from holding Enorama Pharma AB or generate 7.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enorama Pharma AB vs. Xbrane Biopharma AB
Performance |
| Timeline |
| Enorama Pharma AB |
| Xbrane Biopharma |
Enorama Pharma and Xbrane Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enorama Pharma and Xbrane Biopharma
The main advantage of trading using opposite Enorama Pharma and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enorama Pharma position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.| Enorama Pharma vs. Cantargia AB | Enorama Pharma vs. Enzymatica publ AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. BioArctic AB |
| Xbrane Biopharma vs. Hansa Biopharma AB | Xbrane Biopharma vs. Vicore Pharma Holding | Xbrane Biopharma vs. XSpray Pharma AB | Xbrane Biopharma vs. Saniona AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |